AMPH

28.43

0.25% -0.07

Dopo l'orario di chiusura: 28.43

Amphastar Pharmaceuticals Inc (AMPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché AMPH Giù? Forum Previsione

Precedente Chiudi:

$28.50

Aprire:

$28.45

Volume 24 ore:

386.84K

Relative Volume:

0.67

Capitalizzazione di mercato:

$1.35B

Reddito:

$723.55M

Utile/perdita netta:

$157.72M

Rapporto P/E:

9.4767

EPS:

Flusso di cassa netto:

$170.15M

1 W Prestazione:

+0.49%

1M Prestazione:

-9.72%

6M Prestazione:

-40.80%

1 anno Prestazione:

-35.25%

Intervallo 1D:

$28.23

$28.71

Intervallo di 1 settimana:

$27.80

$28.83

Portata 52W:

$25.89

$53.95

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Nome

Amphastar Pharmaceuticals Inc

Settore

Healthcare (1166)

Industria

Drug Manufacturers - Specialty & Generic (1)

Telefono

909-980-9484

Indirizzo

11570 SIXTH STREET, RANCHO CUCAMONGA, CA

Dipendente

2,028

Cinguettio

Prossima data di guadagno

2024-12-06

Ultimi documenti SEC

AMPH's Discussions on Twitter

Confronta AMPH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AMPH Amphastar Pharmaceuticals Inc	28.43	1.35B	723.55M	157.72M	170.15M	3.00
ZTS Zoetis Inc	163.11	73.07B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.05	47.43B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.24	45.72B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.08	17.28B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.81	14.03B	612.78M	-86.37M	-62.91M	-0.87

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-04	Downgrade	Piper Sandler	Overweight → Neutral
2024-11-22	Iniziato	Wells Fargo	Equal Weight
2024-03-05	Iniziato	JP Morgan	Overweight
2023-11-17	Iniziato	BofA Securities	Neutral
2023-07-25	Ripresa	Jefferies	Buy
2022-10-21	Ripresa	Jefferies	Buy
2022-07-29	Iniziato	CapitalOne	Overweight
2022-01-07	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-01-08	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-10-05	Aggiornamento	Northland Capital	Market Perform → Outperform
2020-05-01	Iniziato	Northland Capital	Outperform
2019-03-13	Downgrade	Needham	Buy → Hold
2019-03-13	Downgrade	Piper Jaffray	Overweight → Neutral
2018-08-10	Reiterato	Needham	Buy
2018-03-13	Reiterato	Needham	Buy
2017-12-01	Reiterato	Needham	Buy
2017-11-09	Downgrade	Raymond James	Outperform → Mkt Perform
2017-09-27	Reiterato	Needham	Buy
2017-03-14	Downgrade	Raymond James	Strong Buy → Outperform
2016-08-09	Reiterato	Needham	Buy
2016-05-10	Reiterato	Needham	Buy
2016-02-19	Iniziato	Wells Fargo	Outperform
2015-06-19	Reiterato	Needham	Buy
2015-06-03	Iniziato	Raymond James	Strong Buy
2014-07-21	Iniziato	Needham	Buy

Mostra tutto

Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie

Mar 30, 2025

Raymond James Financial Inc. Takes $3.45 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 30, 2025

Mar 29, 2025

Quantbot Technologies LP Invests $945,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 29, 2025

(AMPH) Investment Report - Stock Traders Daily

Mar 29, 2025

Mar 28, 2025

Fox Run Management L.L.C. Takes $688,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 28, 2025

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award - ACCESS Newswire

Mar 28, 2025

Amphastar Wins FDA Award: How Its Solution to Critical Drug Shortage Signals Major Growth - StockTitan

Mar 28, 2025

Mar 26, 2025

Intech Investment Management LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 26, 2025

Mar 25, 2025

Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - MarketBeat

Mar 25, 2025

Mar 24, 2025

Boston Partners Purchases Shares of 426,636 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 24, 2025

Hypoglycemia Pipeline 2025: FDA Approvals, Therapies, - openPR

Mar 24, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by PNC Financial Services Group Inc. - Defense World

Mar 24, 2025

Mar 23, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Amundi - MarketBeat

Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 23, 2025

Piper Sandler Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - Defense World

Mar 23, 2025

Mar 22, 2025

Charles Schwab Investment Management Inc. Sells 2,544 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 22, 2025

Amphastar stock target cut to $32 by Piper Sandler, maintains neutral - Investing.com Canada

Mar 22, 2025

Mar 21, 2025

Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 21, 2025

Mar 20, 2025

Amundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 20, 2025

Mar 19, 2025